Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 36.3 M36.07 M37.6 M50.84 M51.87 M 176.38 M Research & development 23.07 M24.16 M27.33 M32.19 M33.42 M 117.09 M Operating income -22.77 M-17.96 M-18.34 M-36 M-34.89 M -107.19 M Non-Operating Income, Total 11.07 M-4.13 M-40.06 M-114.01 M-102.97 M -261.18 M Interest expense, net of interest capitalized —326 K1.02 M1.59 M1.45 M 4.38 M Non-Operating Income, excl. Interest Expenses 12.27 M-3.51 M-40.08 M-118.69 M-102.77 M -265.05 M Unusual income/expense -1.2 M-628 K18 K4.69 M-206 K 3.87 M Pretax income -11.7 M-22.09 M-58.4 M-150.01 M-137.86 M -368.37 M Equity in earnings ————— — Taxes 928 K497 K784 K2.45 M1.01 M 4.74 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -12.63 M-22.59 M-59.19 M-152.46 M-138.87 M -373.1 M Discontinued operations ————— — Net income -12.63 M-22.59 M-59.19 M-152.46 M-138.87 M -373.1 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -12.63 M-22.59 M-59.19 M-152.46 M-138.87 M -373.1 M Basic earnings per share (Basic EPS) -0.04-0.07-0.19-0.5-0.4 -1.16 Diluted earnings per share (Diluted EPS) -0.04-0.07-0.19-0.5-0.4 -1.16 Average basic shares outstanding 300.27 M304.13 M309.25 M307.8 M345.52 M — Diluted shares outstanding 300.27 M304.13 M309.25 M307.8 M345.52 M — EBITDA -11.69 M-7.34 M-8.43 M-25.79 M-23.7 M -65.26 M EBIT -22.77 M-17.96 M-18.34 M-36 M-34.89 M -107.19 M Cost of revenue 29.66 M31.12 M34.67 M39.79 M43.75 M 149.33 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 11.08 M10.62 M9.91 M10.21 M11.19 M 41.93 M